The Evaluation of the Risk Factors for Non-Muscle Invasive Bladder Cancer (NMIBC) Recurrence after Transurethral Resection (TURBt) in Chinese Population

Cancer statistics, 2014

(2014) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Are EORTC risk tables suitable for Chinese patients with non-muscle-invasive bladder cancer?

(2014) Weihong Ding et al.   Cancer Epidemiology

The Prognostic Value of T1 Bladder Cancer Substaging: A Single Institution Retrospective Study

(2014) V. Soukup et al.   UROLOGIA INTERNATIONALIS

Long term follow-up in patients with initially diagnosed low grade Ta non-muscle invasive bladder tumors: tumor recurrence and worsening progression

(2014) Hiroaki Kobayashi et al.   BMC Urology

Accuracy of the EORTC risk tables and of the CUETO scoring model to predict outcomes in non-muscle-invasive urothelial carcinoma of the bladder

(2013) E Xylinas et al.   BRITISH JOURNAL OF CANCER

Body mass and smoking are modifiable risk factors for recurrent bladder cancer

(2013) Asaf Wyszynski et al.   CANCER

Recurrence of high-risk bladder cancer: A population-based analysis

(2013) Karim Chamie et al.   CANCER

EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2013

(2013) Marko Babjuk et al.   EUROPEAN UROLOGY

Cancer incidence and mortality in China, 2007

(2012) Wan-qing Chen et al.   Chinese Journal of Cancer Research

Epidemiology and Risk Factors of Urothelial Bladder Cancer

(2012) Maximilian Burger et al.   EUROPEAN UROLOGY

Intravesical therapy for superficial bladder cancer: A systematic review of randomised trials and meta-analyses

(2010) Mike D. Shelley et al.   CANCER TREATMENT REVIEWS

Usefulness of the Spanish Urological Club for Oncological Treatment Scoring Model to Predict Nonmuscle Invasive Bladder Cancer Recurrence in Patients Treated With Intravesical Bacillus Calmette-Guérin Plus Interferon-α

(2010) Henry M. Rosevear et al.   JOURNAL OF UROLOGY

Should All Patients with Non–Muscle-Invasive Bladder Cancer Receive Early Intravesical Chemotherapy after Transurethral Resection? The Results of a Prospective Randomised Multicentre Study

(2009) Sigurdur Gudjónsson et al.   EUROPEAN UROLOGY

Predicting Nonmuscle Invasive Bladder Cancer Recurrence and Progression in Patients Treated With Bacillus Calmette-Guerin: The CUETO Scoring Model

(2009) Jesus Fernandez-Gomez et al.   JOURNAL OF UROLOGY

A Single Instillation of Epirubicin After Transurethral Resection of Bladder Tumors Prevents Only Small Recurrences

(2007) Ingela Berrum-Svennung et al.   JOURNAL OF UROLOGY